28 jun: Vestas/Danske: Fortsat penge til egen finansiering
28 jun: Flügger/SHB: Sænker kursmål efter svagt regnskab
28-06-2012 09:45:00

Commerzbank Places Around 128.3M New Shares At EUR1.27 A Share

Relateret indhold

FRANKFURT--Germany's Commerzbank AG (CBK.XE) Thursday said it placed around 128.3 million newly issued shares with institutional investors.

The 128,335,357 new shares, which were sold to institutional investors at a price of EUR1.27 a share, forms a part of the capital increase of the bank's subscribed capital by about 3.2%, or a total 176,553,636 new shares. The new shares constitute a contribution in kind related to 2011 bonus payments to staff in Commerzbank shares.

Commerzbank said late Wednesday it has strengthened its Core Tier 1 capital by a total of 213.8 million euros (about $266.6 million) by having the majority of employees' 2011 bonuses paid out in Commerzbank shares, a step toward improving the bank's capital base in light of stricter regulation.

Commerzbank and Deutsche Bank act as joint bookrunner in the coordinated sales transaction.

The new shares will be traded on exchanges as of July 2.

The German government, through its SoFFin financial-markets-stabilization fund, will continue to hold 25% plus one share in Commerzbank.

A corresponding portion of the SoFFin's silent participation is intended to be converted into shares, Commerzbank added.

Write to Ulrike Dauer at ulrike.dauer@dowjones.com

(END) Dow Jones Newswires

June 28, 2012 03:45 ET (07:45 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Norwegian har skrevet toårig overenskomst med kabinepersonalet

05-02-2016 15:55:23
Norwegians kabineselskaber, Norwegian Kabinforening (NK) og fagforeningen Parat har de seneste uger forhandlet om en ny overenskomst for de kabineansatte i Danm..

Genmab/Danske: Storudsalg af aktier bør ikke give panderynker

05-02-2016 12:17:09
På overfladen kunne det se mystisk ud, at ventureselskabet Johnson & Johnson Innovation har solgt en stor del sin beholdning af aktier i biotekselskabet Genmab...

Aktier/åbning: Genmab falder markant i de første handler

05-02-2016 09:29:22
Det amerikanske udslag af aktier i Genmab får kursen til at droppe fredag morgen med 7,6 pct. til 741,50 kr. Det er Johnson & Johnson Innovation, der har solgt ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Deutsche Bank AG 16,89 -0,4% Fald i aktiekurs
Commerzbank AG ORD NPV 7,32 2,4% Stigning i aktiekurs
Commerzbank I 8,06 3,1% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
7. februar 2016 00:17:31
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20160125.1 - EUROWEB6 - 2016-02-07 00:17:31 - 2016-02-07 00:17:31 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x